Cargando…

Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma

More than 50% of human cancers harbor TP53 mutations and increased expression of Mouse double minute 2 homolog (MDM2), which contribute to cancer progression and drug resistance. Renal cell carcinoma (RCC) has an unusually high incidence of wild-type p53, with a mutation rate of less than 4%. MDM2 i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Joon Hee, Lee, Seon-Hyeong, Lee, Jae-Seon, Oh, Su-Jin, Ha, Ji Sun, Choi, Hyun-Jung, Kim, Soo-Youl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349864/ https://www.ncbi.nlm.nih.gov/pubmed/32560270 http://dx.doi.org/10.3390/cells9061475

Ejemplares similares

Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma
por: Lee, Seon-Hyeong, et al.
Publicado: (2020)

Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition
por: Lee, Seon-Hyeong, et al.
Publicado: (2018)

Transglutaminase 2 Promotes Autophagy by LC3 Induction through p53 Depletion in Cancer Cell
por: Kang, Joon Hee, et al.
Publicado: (2019)

A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor
por: Sohn, Joonhong, et al.
Publicado: (2010)

A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2
por: Kim, Soo-Youl, et al.
Publicado: (2020)

ATP Production Relies on Fatty Acid Oxidation Rather than Glycolysis in Pancreatic Ductal Adenocarcinoma
por: Lee, Jae-Seon, et al.
Publicado: (2020)

Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC
por: Lee, Soohyun, et al.
Publicado: (2018)

Transglutaminase 2 Expression and Its Prognostic Significance in Clear Cell Renal Cell Carcinoma
por: Park, Min Jee, et al.
Publicado: (2015)

New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds
por: Kim, Soo-Youl
Publicado: (2018)

Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation
por: Lee, Jae-Seon, et al.
Publicado: (2019)

Oxoglutarate Carrier Inhibition Reduced Melanoma Growth and Invasion by Reducing ATP Production
por: Lee, Jae-Seon, et al.
Publicado: (2020)

Significance of the Syndecan-4-Transglutaminase-2 Interaction
por: Verderio, Elisabetta, et al.
Publicado: (2010)

Suppression of Transglutaminase-2 is Involved in Anti-Inflammatory Actions of Glucosamine in 12-O-Tetradecanoylphorbol-13-Acetate-Induced Skin Inflammation
por: Park, Mi Kyung, et al.
Publicado: (2012)

Effects of Transglutaminase 2 Inhibition on Ventilator-Induced Lung Injury
por: Suh, In Bum, et al.
Publicado: (2014)

PIG3 Regulates p53 Stability by Suppressing Its MDM2-Mediated Ubiquitination
por: Jin, Min, et al.
Publicado: (2017)

Involvement of Transglutaminase-2 in α-MSH-Induced Melanogenesis in SK-MEL-2 Human Melanoma Cells
por: Kim, Hyun Ji, et al.
Publicado: (2014)

Design and Synthesis of a Novel 4-aryl-N-(2-alkoxythieno [2,3-b]pyrazine-3-yl)-4-arylpiperazine-1-carboxamide DGG200064 Showed Therapeutic Effect on Colon Cancer through G2/M Arrest
por: Lee, Eun-Sil, et al.
Publicado: (2022)

Ethacrynic Acid Inhibits Sphingosylphosphorylcholine-Induced Keratin 8 Phosphorylation and Reorganization via Transglutaminase-2 Inhibition
por: Byun, Hyun Jung, et al.
Publicado: (2013)

The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer
por: Lee, Seon-Hyeong, et al.
Publicado: (2020)

Discovery of a novel target for renal cell carcinoma: transglutaminase 2
por: Kang, J H, et al.
Publicado: (2016)

Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation
por: Lee, Jae-Seon, et al.
Publicado: (2019)

Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells
por: Oh, Keunhee, et al.
Publicado: (2011)

Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2
por: Thangaraju, Kiruphagaran, et al.
Publicado: (2017)

Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells
por: Her, Nam-Gu, et al.
Publicado: (2018)

Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling
por: Lee, Jae-Seon, et al.
Publicado: (2020)

Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC
por: Lee, Jae-Seon, et al.
Publicado: (2016)

Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion
por: Kang, Joon Hee, et al.
Publicado: (2016)

Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer
por: Choi, Chang-Min, et al.
Publicado: (2011)

Transglutaminase-2 Is Involved in All-Trans Retinoic Acid-Induced Invasion and Matrix Metalloproteinases Expression of SH-SY5Y Neuroblastoma Cells via NF-κB Pathway
por: Lee, Hye Ja, et al.
Publicado: (2012)

Aldehyde dehydrogenase is used by cancer cells for energy metabolism
por: Kang, Joon Hee, et al.
Publicado: (2016)

Primary cardiac sarcomas: A clinicopathologic study in a single institution with 25 years of experience with an emphasis on MDM2 expression and adjuvant therapy for prognosis
por: Cho, Haeyon, et al.
Publicado: (2023)

Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma
por: Nezir, Ayca Ece, et al.
Publicado: (2019)

Midazolam Ameliorates Hyperglycemia-Induced Glomerular Endothelial Dysfunction by Inhibiting Transglutaminase 2 in Diabetes
por: Seo, Jae-Ah, et al.
Publicado: (2022)

Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway
por: Kim, Woo-Shin, et al.
Publicado: (2017)

Transglutaminase 2 as a Marker for Inflammation and Therapeutic Target in Sepsis
por: Su, Ting, et al.
Publicado: (2021)

Anti-oxidizing effect of the dichloromethane and hexane fractions from Orostachys japonicus in LPS-stimulated RAW 264.7 cells via upregulation of Nrf2 expression and activation of MAPK signaling pathway
por: Lee, Hyeong-Seon, et al.
Publicado: (2014)

Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death
por: Tatsukawa, H, et al.
Publicado: (2016)

Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers
por: Cho, Sung-Yup, et al.
Publicado: (2020)

S-nitrosylation of transglutaminase 2 impairs fatty acid-stimulated contraction in hypertensive cardiomyocytes
por: Jeong, Eui Man, et al.
Publicado: (2018)

Reply to Krupenko et al., Comment on “Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer Cancers 2020, 12, 1382”
por: Lee, Seon-Hyeong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_duaf1o500m5j9h2hqi9nnduhc7